ArticleOncotarget2017

miR-564 inhibits hepatocellular carcinoma cell proliferation and invasion by targeting the GRB2-ERK1/2-AKT axis.

Chaojie Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.